Tobacco use and response to immune checkpoint inhibitor therapy in non-small cell lung cancer

HIGHLIGHTS

  • who: Lucy K. Corke and colleagues from the Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network Toronto, Toronto, ON M G , Canada have published the research: Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer, in the Journal: (JOURNAL) of 24/08/2022
  • how: The authors identified landmark clinical trials and subsequently also reviewed trials on clinicaltrials.gov and similar systematic reviews evaluating ICI in lung cancer to help with identifying relevant ICI trials in lung cancer. Data were analyzed using . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?